JOVIYON
LIVE

Serial Number

99476908

Owner

Amgen Inc.

Attorney

Elsa D. Lemoine

Filing Date

Nov 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

JOVIYON Trademark

Serial Number: 99476908

JOVIYON is a trademark filed by Amgen Inc. on November 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Amgen Inc. (28 trademarks)

One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Entity Type: 03

Trademark Details

Filing Date

November 3, 2025

Registration Date

Not Registered

Published for Opposition

September 29, 2026

Goods & Services

Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases, blood diseases, bone and skeletal diseases, cancer, cardiovascular diseases, sleep apnea, central nervous system diseases, cluster headaches, coronavirus disease, and Crohn's disease; Pharmaceutical preparations for treating dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammatory diseases and disorders, kidney diseases, liver diseases, lupus, and mental disorders; Pharmaceutical preparations for treating metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative or neurological diseases and disorders, obesity, chronic weight management, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 29, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 29, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 8, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 8, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2025 NWOS
NEW APPLICATION ENTERED
Nov 3, 2025 NWAP